Temporada, Cemarmimi .

HRN: 26-17-35  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2024
CEFUROXIME 1.5GM (VIAL)
12/12/2024
12/12/2024
IVT
1.5grams
Loading Dose
For CS
Waiting Final Action 
12/12/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/12/2024
12/18/2024
IVT
900mg
Q8hrs
Post Op Prophylaxis
Waiting Final Action 
12/12/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
12/12/2024
12/18/2024
IVT
240mg
OD
Post Op Prophylaxis
Waiting Final Action 
12/12/2024
MUPIROCIN 2%, 15G (TUBE)
12/12/2024
12/18/2024
TOPICAL
Apply
OD
Post Op Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: